论文部分内容阅读
目的:分析动脉化疗在妇科恶性肿瘤多途径化疗中价值。方法:80例妇科恶性肿瘤患者分组为卵巢肿瘤组和子宫肿瘤组。分别采用单一静脉化疗和静脉+腹腔化疗以及单一动脉化疗、动脉化疗+静脉+腹腔联合化疗。结果:卵巢恶性肿瘤组中:对患者采用多途径联合用药进行化疗治疗的近期效果优于其他方式治疗。子宫恶性肿瘤组:对患者采用单一动脉化疗和多途径联合化疗治疗效果明显优于其他方式治疗。结论:对妇科恶性肿瘤患者采用动脉化疗联合静脉与腹腔化疗治疗效果显著。尤其是对卵巢恶性肿瘤患者的治疗效果更佳。
Objective: To analyze the value of arterial chemotherapy in multi-path chemotherapy of gynecologic malignancies. Methods: 80 cases of gynecological malignant tumor patients were divided into ovarian tumor group and uterine tumor group. A single intravenous chemotherapy and intravenous + intraperitoneal chemotherapy and single arterial chemotherapy, arterial chemotherapy + intravenous + abdominal combined chemotherapy. Results: In the ovarian malignancy group, the immediate effect of chemotherapy on patients using multi-channel combination therapy is superior to other methods. Uterine malignant tumor group: the use of single-artery chemotherapy and multi-channel chemotherapy in patients with chemotherapy was significantly better than the other treatment. Conclusion: Arterial chemotherapy combined with intravenous and intraperitoneal chemotherapy in patients with gynecologic malignancies is effective. In particular, the treatment of ovarian cancer patients better.